Cox DA, Wang H, Nicolay C, Bethel MA, et al. Effect of expanded dulaglutide weekly doses (3.0 mg and 4.5 mg) on cardiovascular disease risk factors in participants with type 2 diabetes at increased cardiovascular disease risk: a post hoc analysis of the AWARD-11 study. Diabetes Obes Metab 2022 May 11. doi: 10.1111/dom.14762.
PMID: 35546790